Siming Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Siming Yu has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
Wei Xue
7 shared publications- Wei Xue
Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China
7 shared publications Xiling Song
Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Department of Biomedical Engineering, Jinan University, Guangzhou, 510632, China
6 shared publicationsWei Liu
Department of Orthopedics, The First Affiliated Hospital, Jinan University, Guangzhou, 510632, China
5 shared publicationsWenkang Liu
Department of Oncology, Research Center of Cancer Diagnosis and Therapy, the First Affiliated Hospital, Jinan University, Guangzhou, 510632, China
5 shared publications- Dong Ma
Department of Burn and Plastic Surgery Guangzhou Red Cross Hospital Jinan University Guangzhou China
4 shared publications
Latest Publications
- Open Access
- 4 June 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Bacterial outer membrane vesicle-based biomimetic nitric oxide-releasing nanogenerator for boosting antitumor efficiency of enzyme dynamic therapy via augmented autophagy and immunoactivation
Recently, enzyme dynamic therapy (EDT) has attracted great attention in cancer therapy. Nevertheless, the limited H2O2 concentration in the tumor microenvironment (TME) and the induction of autophagy significantly impair the anticancer efficacy of EDT. Herein, a bacterial outer membrane vesicles (OMVs)-based nitric oxide (NO)-releasing nanogenerator was synthesized to enhance the anticancer efficacy of EDT. Specifically, hollow polydopamine nanospheres (HPDA) were first prepared and used as a carrier to load lactate oxidase (LOX), the NO-releasing donor BNN6 and chloroperoxidase (CPO), followed by surface coating with OMVs to obtain the biomimetic nanogenerator HPDA@LBC@OMV. Due to the excellent tumor-targeting ability of OMVs, HPDA@LBC@OMV displayed highly efficient accumulation in 4T1 tumor tissues. In the TME, HPDA@LBC@OMV firstly catalyzed lactic acid to produce a substantial amount of H2O2, which subsequently triggered the simultaneous generation of NO and singlet oxygen (1O2) through cascade catalytic reactions, ultimately resulting in significant inhibition of 4T1 tumors. Mechanistic studies revealed that the synergistic NO/1O2 anticancer effect inhibited 4T1 tumors by inducing excessive autophagy. More importantly, it was demonstrated that the synergistic effect-induced excessive autophagy effectively triggered immunogenic cell death (ICD) in dying tumor cells, thereby further activating the body's immune response by converting "cold" tumors into "hot" tumors to enhance anticancer immunotherapy.
- 4 June 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessBacterial outer membrane vesicle-based biomimetic nitric oxide-releasing nanogenerator for boosting antitumor efficiency of enzyme dynamic therapy via augmented autophagy and immunoactivation
Recently, enzyme dynamic therapy (EDT) has attracted great attention in cancer therapy. Nevertheless, the limited H2O2 concentration in the tumor microenvironment (TME) and the induction of autophagy significantly impair the anticancer efficacy of EDT. Herein, a bacterial outer membrane vesicles (OMVs)-based nitric oxide (NO)-releasing nanogenerator was synthesized to enhance the anticancer efficacy of EDT. Specifically, hollow polydopamine nanospheres (HPDA) were first prepared and used as a carrier to load lactate oxidase (LOX), the NO-releasing donor BNN6 and chloroperoxidase (CPO), followed by surface coating with OMVs to obtain the biomimetic nanogenerator HPDA@LBC@OMV. Due to the excellent tumor-targeting ability of OMVs, HPDA@LBC@OMV displayed highly efficient accumulation in 4T1 tumor tissues. In the TME, HPDA@LBC@OMV firstly catalyzed lactic acid to produce a substantial amount of H2O2, which subsequently triggered the simultaneous generation of NO and singlet oxygen (1O2) through cascade catalytic reactions, ultimately resulting in significant inhibition of 4T1 tumors. Mechanistic studies revealed that the synergistic NO/1O2 anticancer effect inhibited 4T1 tumors by inducing excessive autophagy. More importantly, it was demonstrated that the synergistic effect-induced excessive autophagy effectively triggered immunogenic cell death (ICD) in dying tumor cells, thereby further activating the body's immune response by converting "cold" tumors into "hot" tumors to enhance anticancer immunotherapy.
- Open Access
- 18 May 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103216
Diselenide-bridged mesoporous silica nanoplatform for baicalin delivery facilitates spinal cord injury repair via CHCHD2-mediated mitochondrial homeostasis restoration
- 18 May 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103216
Open AccessDiselenide-bridged mesoporous silica nanoplatform for baicalin delivery facilitates spinal cord injury repair via CHCHD2-mediated mitochondrial homeostasis restoration
- Open Access
- 25 October 2025
- Published by Elsevier in Materials Today Bio
- Vol. 35, 102457
Pseudomonas aeruginosa-targeted mesoporous gold nanorod nanogenerator: NIR laser-triggered alkyl radical generation for enhanced bacterial wound treatment
- 25 October 2025
- Published by Elsevier in Materials Today Bio
- Vol. 35, 102457
Open AccessPseudomonas aeruginosa-targeted mesoporous gold nanorod nanogenerator: NIR laser-triggered alkyl radical generation for enhanced bacterial wound treatment
- 9 October 2025
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 37 (20) , 8470-8471
Correction to “Chitosan- graft -Poly( L -lysine) Dendron-Assisted Facile Self-Assembly of Au Nanoclusters for Enhanced X-ray Computer Tomography Imaging and Precise MMP-9 Plasmid shRNA Delivery”
- 9 October 2025
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 37 (20) , 8470-8471
Correction to “Chitosan- graft -Poly( L -lysine) Dendron-Assisted Facile Self-Assembly of Au Nanoclusters for Enhanced X-ray Computer Tomography Imaging and Precise MMP-9 Plasmid shRNA Delivery”
- Open Access
- 28 May 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101912
Cu-Fe bimetallic peroxide-based nanozyme with microenvironment-triggered cascade catalysis for synergistic hydroxyl radical, nitric oxide, and oxygen generation in trimodal wound infection therapy
- 28 May 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101912
Open AccessCu-Fe bimetallic peroxide-based nanozyme with microenvironment-triggered cascade catalysis for synergistic hydroxyl radical, nitric oxide, and oxygen generation in trimodal wound infection therapy
- 21 April 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (14) , e2405009
Near Infrared II Laser‐Boosted Peroxynitrite Generation Hollow Copper Single Atom Nanozyme for Effective Bacterial Infection Treatment
The peroxynitrite anion (ONOO−) is the product of a specific reaction between nitric oxide (NO) and the superoxide anion (O2•−), showing great potential for treating multidrug‐resistant bacterial infections. However, antibacterial materials with highly efficient ONOO− controlled release properties are lacking. In this study, hollow copper single atom nanozyme (Cu HSAz) with oxidase (OXD)‐mimicking property is rationally designed and used for the first time as effective delivery carrier for the NO donor N, N′‐di‐sec‐butyl‐N, N′‐dinitroso‐1, 4‐phenylenediamine (BNN6), obtaining the nanozyme Cu HSAz@BNN6. Upon near infrared (NIR)‐II laser irradiation, Cu HSAz@BNN6 simultaneously releases substantial amounts of NO and O2•−, which subsequently lead to the ONOO−boosting via a cascade reaction. Remarkably, ONOO− displays excellent antibacterial efficiency by considerably inhibiting the activity of methicillin‐resistant Staphylococcus aureus (MRSA) activity. Moreover, ONOO− is effective in treating MRSA‐associated wound infections and promoting wound healing. An antibacterial mechanism study reveals that ONOO−triggers MRSA death by firstly damaging the MRSA membrane, followed by destructing MRSA metabolism to cut the adenosine triphosphate energy supply and boosts intracellular reactive oxygen species generation, which subsequently depletes intracellular glutathione and caused DNA breakage.
- 21 April 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (14) , e2405009
Near Infrared II Laser‐Boosted Peroxynitrite Generation Hollow Copper Single Atom Nanozyme for Effective Bacterial Infection Treatment
The peroxynitrite anion (ONOO−) is the product of a specific reaction between nitric oxide (NO) and the superoxide anion (O2•−), showing great potential for treating multidrug‐resistant bacterial infections. However, antibacterial materials with highly efficient ONOO− controlled release properties are lacking. In this study, hollow copper single atom nanozyme (Cu HSAz) with oxidase (OXD)‐mimicking property is rationally designed and used for the first time as effective delivery carrier for the NO donor N, N′‐di‐sec‐butyl‐N, N′‐dinitroso‐1, 4‐phenylenediamine (BNN6), obtaining the nanozyme Cu HSAz@BNN6. Upon near infrared (NIR)‐II laser irradiation, Cu HSAz@BNN6 simultaneously releases substantial amounts of NO and O2•−, which subsequently lead to the ONOO−boosting via a cascade reaction. Remarkably, ONOO− displays excellent antibacterial efficiency by considerably inhibiting the activity of methicillin‐resistant Staphylococcus aureus (MRSA) activity. Moreover, ONOO− is effective in treating MRSA‐associated wound infections and promoting wound healing. An antibacterial mechanism study reveals that ONOO−triggers MRSA death by firstly damaging the MRSA membrane, followed by destructing MRSA metabolism to cut the adenosine triphosphate energy supply and boosts intracellular reactive oxygen species generation, which subsequently depletes intracellular glutathione and caused DNA breakage.
Neutrophil‐Mimicking Nanozyme with Cascade Catalytic Releasing Nitric Oxide and Signet Oxygen Property for Synergistic Bimodal Therapy of Methicillin‐Resistant Staphylococcus Aureus Infections
Recently, chloroperoxidase (CPO)‐mediated enzyme dynamic therapy (EDT) by mimicking the antipathogen function of neutrophils via generating highly active signet oxygen ( 1 O 2 ) has attracted great interest in biomedical applications. However, the therapeutic efficiency of EDT is largely restricted by the low CPO delivery efficiency and insufficient hydrogen peroxide (H 2 O 2 ) supply. In the present work, a neutrophil‐mimicking nanozyme of MGBC with high CPO delivery efficiency, H 2 O 2 self‐supply, and enzyme‐cascade catalytic properties is designed for high‐efficient treatment of methicillin‐resistant Staphylococcus aureus ( MRSA ) infections. In the infection microenvironment, MGBC can effectively catalyze glucose to self‐supply substantial H 2 O 2 , which enables long‐lasting 1 O 2 generation via the CPO‐mediated catalytic reaction. At the meantime, MGBC can also catalyze H 2 O 2 to sustainably release NO for gas therapy (GT), which synergistically strengthens the therapeutic effect of EDT. As a result, MGBC displayed effective MRSA ‐killing and MSRA biofilms‐eradicating properties, and high efficiency in treating both MRSA infected full‐thickness excision wounds and subcutaneous MRSA infection by exerting the synergistic bimodal EDT/GT therapeutic effects. In‐depth mechanism study revealed that the synergistic EDT/GT antibacterial effects of MGBC can attenuate the drug resistance and toxicity of MRSA by significantly downregulating quorum sensing, multidrug efflux, virulence, and biofilm formation‐related genes.
Neutrophil‐Mimicking Nanozyme with Cascade Catalytic Releasing Nitric Oxide and Signet Oxygen Property for Synergistic Bimodal Therapy of Methicillin‐Resistant Staphylococcus Aureus Infections
Recently, chloroperoxidase (CPO)‐mediated enzyme dynamic therapy (EDT) by mimicking the antipathogen function of neutrophils via generating highly active signet oxygen ( 1 O 2 ) has attracted great interest in biomedical applications. However, the therapeutic efficiency of EDT is largely restricted by the low CPO delivery efficiency and insufficient hydrogen peroxide (H 2 O 2 ) supply. In the present work, a neutrophil‐mimicking nanozyme of MGBC with high CPO delivery efficiency, H 2 O 2 self‐supply, and enzyme‐cascade catalytic properties is designed for high‐efficient treatment of methicillin‐resistant Staphylococcus aureus ( MRSA ) infections. In the infection microenvironment, MGBC can effectively catalyze glucose to self‐supply substantial H 2 O 2 , which enables long‐lasting 1 O 2 generation via the CPO‐mediated catalytic reaction. At the meantime, MGBC can also catalyze H 2 O 2 to sustainably release NO for gas therapy (GT), which synergistically strengthens the therapeutic effect of EDT. As a result, MGBC displayed effective MRSA ‐killing and MSRA biofilms‐eradicating properties, and high efficiency in treating both MRSA infected full‐thickness excision wounds and subcutaneous MRSA infection by exerting the synergistic bimodal EDT/GT therapeutic effects. In‐depth mechanism study revealed that the synergistic EDT/GT antibacterial effects of MGBC can attenuate the drug resistance and toxicity of MRSA by significantly downregulating quorum sensing, multidrug efflux, virulence, and biofilm formation‐related genes.